← Scoopfeeds — Intelligent news, curated.
GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports
business

GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports

Investing.com · Jun 9, 2026, 1:55 AM · Also reported by 2 other sources

GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports

Read full story on Investing.com → More top stories

Also covered by

Financial Times GSK in talks to buy cancer biotech Nuvalent for more than $9bn Bloomberg Markets GSK in Talks to Buy Nuvalent for More Than $9 Billion: FT

More in business

Investing.com
China trade balance rises more than expected in May on strong exports
Investing.com
Ciena prices $2.5 billion convertible notes offering
Investing.com
South Korea’s cabinet approves decree on $350 billion US investment plan
Bloomberg Markets
Nifty Swings Rise as War Risk Unnerves India Stock Bulls
CNBC
China trade defies Iran war drag as exports, imports beat estimates in May
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop